Tickerplace logo

Tickerplace

Sangamo Therapeutics, Inc. logo

SGMOSangamo Therapeutics, Inc.

SGMO Stock Price, Valuation & Chart | Sangamo Therapeutics, Inc.

Compare
$0.070+0.00 (+0.00%)

At close · 01 July 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologySGMO intrinsic valueSGMO calculated fair value vs price
OverviewFinancialsDividendsRatios

SGMO Historical price chart

SGMO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization30.66M
PE Ratio-0.2
EPS-0.37
Trading Volume28.50M
Today's High/Low0.13/0.06
Dividend Yield0.00
52 Week High/Low0.77/0.06
Shares Outstanding414.29M
SGMO Financial Statement
SGMO Analyst ratings
SGMO Analysis & performance metrics

SGMO Company profile

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform…

SGMO Management team

Management
Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.CEO
Chief Executive Officer, President & Director
Gregory Davis Ph.D.
Head of Research & Technology
Stephanie J. Seiler CLP
Vice President and Head of Business Development & Alliance Management
Scott B. Willoughby
Senior Vice President, Chief Legal Officer & Corporate Secretary
David Ojala
Scientist II - Discovery & Translational Research
Nathalie Dubois-Stringfellow Ph.D.
Senior Vice President & Chief Development Officer
Louise Wilkie
Head of Global Corporate Communications & Investor Relations
Phillip Ramsey
Chief Technical Officer
Total 8 executives

SGMO Frequently asked questions

What is Sangamo Therapeutics, Inc. (SGMO) Stock Price?

Current stock price of Sangamo Therapeutics, Inc. (SGMO) stock is $0.070. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Sangamo Therapeutics, Inc. (SGMO) stock is 28.50M.

Last updated at 01 July 2026, 08:00 pm.

Why is the Sangamo Therapeutics, Inc. (SGMO) stock price going up or down today?

The stock price of Sangamo Therapeutics, Inc. (SGMO) can change with earnings, company news, and overall market sentiment. Sangamo Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Sangamo Therapeutics, Inc. stock expensive at its current price?

Whether Sangamo Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SGMO on this page is -0.20. EPS on this page is -0.37. Compare those figures with peers and growth expectations before deciding if the current Sangamo Therapeutics, Inc. price is justified.

How has the stock price of Sangamo Therapeutics, Inc. (SGMO) performed historically?

Historical performance for Sangamo Therapeutics, Inc. (SGMO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SGMO reacted to past earnings and market events.

Should I buy Sangamo Therapeutics, Inc. (SGMO) stock, at this price?

Buying Sangamo Therapeutics, Inc. (SGMO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.